Search Results

You searched for : cisplatin

	Chemotherapy Drug Linked to Long-Term Hearing Loss in Cancer Survivors Researchers hope that these findings will encourage the exploration of alternative chemotherapy protocols that reduce the risk of hearing loss. This includes preventive measures and ... Jul 05
	Venus Remedies consolidates in ASEAN, gets marketing approval for six chemotherapy drugs from the Philippines The $4.20-billion pharmaceutical market of the Philippines accounts for a significant market for Venus Remedies from the ASEAN region as the company moves ... Nov 04
	European Commission approves Teysuno in metastatic colorectal cancer Latest Corporate news updates; Pharma Feb 3rd 2022... Feb 03
	Bristol Myers Squibb Provides Update on CheckMate -651 Trial Evaluating Opdivo Plus Yervoy Versus EXTREME Regimen as First-Line Treatment for Squamous Cell Carcinoma ... Jul 17
	Debiopharm grants exclusive license to Merck for Xevinapant This worldwide exclusive license to Merck KGaA, Darmstadt, Germany for the development and commercialization of Xevinapant ... Mar 03
	FDA Approves Amgen's RIABNIâ„¢ (rituximab-arrx), A Biosimilar To RituxanÂ® (rituximab) Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved RIABNIâ„¢ (rituximab-arrx), a biosimilar to RituxanÂ® (rituximab)... Dec 18
	Galera Therapeutics Announces Positive Interim Data from First Cohort of Patients in Pilot Phase 1/2 Clinical Trial of GC4419 in Pancreatic Cancer Galera Therapeutics Announces Positive Interim Data from First Cohort of Patients in Pilot Phase 1/2 Clinical Trial of GC4419 in Pancreatic Cancer... Oct 24
	US FDA approves drug combination for treating mesothelioma US FDA approved for the first-line treatment of adults with malignant pleural mesothelioma that cannot be removed by surgery... Oct 05
	Lupin Launches Fosaprepitant for injection ; emetogenic cancer chemotherapy 150 mg Single-Dose Vial, having received an approval from the United States Food and Drug Administration (U.S. FDA) earlier.... Sep 28
	After Japan, EU also approves Imfinzi for lungs cancer After Japan, EU approves AstraZeneca Imfinzi , along with chemotherapy it could treat small cell lung cancer... Sep 02
	Imfinzi from AstraZeneca approved in Japan for lung cancer treatment Imfinzi gets approval in Japan currently FDA has issued it Priority Review status for lungs and bladder cancer treatment... Aug 21
	Green tea -For weightloss and more ... Mar 09
	ERBITUX Approved for First-line Use in China in Patients With Recurrent and/ Metastatic Squamous Cell Carcinoma of the Head and Neck Approval is for ERBITUX in combination with platinum-based therapy with fluorouracil for the first-line treatment of Head and Neck cancer... Mar 03
	Council for Healthcare and Pharma Emphasizes Need to Strengthen System for Treatment of Paediatric Cancers Headquartered in New Delhi, India, CHP focuses on Africa, Brazil, China, Germany, India, Japan, UK and the USA. Its important areas of work are in ... Feb 17
	Neuroblastoma drug goes through successful drug trials Aptorum Group Limited , a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces positive data and development in ... Feb 12
	IASLC World Conference on Lung Cancer--Summary of the Presidential Symposium Research This is a summary of research presented this morning at the International Association for the Study of Lung Cancer's World Conference on Lung Cancer. ... Sep 12
16 Matching result(s) found!

-Advertisements-

Trending Now
	Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
	International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
	The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
	Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
	Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
	In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
	Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
	Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
	10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
	Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
	The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
	Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
	A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
	The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
	ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
	The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
	Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
	Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
	AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
	Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024

Search Results

Chemotherapy Drug Linked to Long-Term Hearing Loss in Cancer Survivors

Venus Remedies consolidates in ASEAN, gets marketing approval for six chemotherapy drugs from the Philippines

European Commission approves Teysuno in metastatic colorectal cancer

Bristol Myers Squibb Provides Update on CheckMate -651 Trial Evaluating Opdivo Plus Yervoy Versus EXTREME Regimen as First-Line Treatment for Squamous Cell Carcinoma

Debiopharm grants exclusive license to Merck for Xevinapant

FDA Approves Amgen's RIABNIâ„¢ (rituximab-arrx), A Biosimilar To RituxanÂ® (rituximab)

Galera Therapeutics Announces Positive Interim Data from First Cohort of Patients in Pilot Phase 1/2 Clinical Trial of GC4419 in Pancreatic Cancer

US FDA approves drug combination for treating mesothelioma

Lupin Launches Fosaprepitant for injection ; emetogenic cancer chemotherapy

After Japan, EU also approves Imfinzi for lungs cancer

Imfinzi from AstraZeneca approved in Japan for lung cancer treatment

Green tea -For weightloss and more

ERBITUX Approved for First-line Use in China in Patients With Recurrent and/ Metastatic Squamous Cell Carcinoma of the Head and Neck

Council for Healthcare and Pharma Emphasizes Need to Strengthen System for Treatment of Paediatric Cancers

Neuroblastoma drug goes through successful drug trials

IASLC World Conference on Lung Cancer--Summary of the Presidential Symposium Research

Trending Now